Allogeneic cell-based therapies for individuals with recessive dystrophic epidermolysis bullosa
Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of inherited blistering skin diseases that affect 500,000 individuals worldwide. The clinically more severe recessive dystrophic (RDEB) variant affects ~5% of EB individuals with a prevalence of 8 per one million of the p...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2017
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.713111 |